newsfilter
← Latest News
GlobeNewswire·

Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights

- Phase 2 LUNA interim analysis to be presented at ASRS Annual Scientific Meeting on July 17th, 2024 in Stockholm, Sweden - $193.3 million in cash, cash equivalents and short-term investments expected to fund operations